Does the use of dihydroartemisinin-piperaquine in treating patients with uncomplicated falciparum malaria reduce the risk for recurrent new falciparum infection more than artemether-lumefantrine?

Malaria Research and Treatment

Volumn 2014, Issue , 2014, Pages

  Akpaloo, Wisdom ^a,b   Purssell, Edward ^b  

^a AngloGold Ashanti Hospital   (Ghana)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; BENFLUMETOL; DIHYDROARTEMISININ PLUS PIPERAQUINE; DUOCOTEXIN; UNCLASSIFIED DRUG;

AFRICA SOUTH OF THE SAHARA; DISEASE TRANSMISSION; DRUG TREATMENT FAILURE; HUMAN; INFECTION RISK; MALARIA FALCIPARUM; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RECURRENT INFECTION; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SYSTEMATIC REVIEW;

EID: 84959123136     PISSN: 20908075     EISSN: 20444362     Source Type: Journal    
DOI: 10.1155/2014/263674     Document Type: Review

References (38)

1. World Health Organization, Global Malaria Program: World Malaria Report 2012 Geneva, Switzerland World Health Organization. http://www.who.int/malaria/ publications/world-malaria-report-2012/wmr2012-full-report.pdf
2. United Nations Millennium Project, Investing in Development: A Practical Plan to Achieve the Millennium Development Goals 2005 New York, NY, USA United Nations Millennium Project
3. Murray C. J. L., Rosenfeld L. C., Lim S. S., Andrews K. G., Foreman K. J., Haring D., Fullman N., Naghavi M., Lozano R., Lopez A. D., Global malaria mortality between 1980 and 2010: a systematic analysis. The Lancet 2012 379 9814 413 431 2-s2.0-84856679687 10.1016/S0140-6736(12)60034-8
4. Schantz-Dunn J., Nour N. M., Malaria and pregnancy: a global health perspective. Reviews in Obstetrics and Gynecology 2009 2 3 186 192
5. World Health Organization, World Malaria Report 2010 Geneva, Switzerland World Health Organization. http://www.who.int/malaria/world-malaria-report-2010/ worldmalariareport2010.pdf
6. United Nations, The Millennium Development Goals Report 2011 New York, NY, USA United Nations. http://mdgs.un.org/unsd/mdg/Resources/Static/Products/ Progress2011/11-31339%20(E)%20MDG%20Report%202011-Book%20LR.pdf
7. Hetzel M. W., Obrist B., Lengeler C., Msechu J. J., Nathan R., Dillip A., Makemba A. M., Mshana C., Schulze A., Mshinda H., Obstacles to prompt and effective malaria treatment lead to low community-coverage in two rural districts of Tanzania. BMC Public Health 2008 8, article 317 2-s2.0-44449094857 10.1186/1471-2458-8-317
8. Chuma J., Abuya T., Memusi D., Juma E., Akhwale W., Ntwiga J., Nyandigisi A., Tetteh G., Shretta R., Amin A., Reviewing the literature on access to prompt and effective malaria treatment in Kenya: implications for meeting the Abuja targets. Malaria Journal 2009 8 1, article 243 2-s2.0-72449139084 10.1186/1475-2875-8-243
9. Chuma J., Okungu V., Molyneux C., Barriers to prompt and effective malaria treatment among the poorest population in Kenya. Malaria Journal 2010 9 1, article 144 2-s2.0-77952728019 10.1186/1475-2875-9-144
10. Wongsrichanalai C., Pickard A. L., Wernsdorfer W. H., Meshnick S. R., Epidemiology of drug-resistant malaria. Lancet Infectious Diseases 2002 2 4 209 218 2-s2.0-0036242351 10.1016/S1473-3099(02)00239-6 (Pubitemid 34464751)
11. World Health Organization, Antimalarial Drug Combination Therapy: Report of a World Health Organization Technical Consultation 2001 Geneva, Switzerland World Health Organization. http://whqlibdoc.who.int/hq/2001/WHO-CDS-RBM-2001.35. pdf
12. World Health Organization, Guidelines for the Treatment of Malaria 2006 Geneva, Switzerland World Health Organization. http://whqlibdoc.who.int/ publications/2010/9789241547925-eng.pdf
13. Adjuik M., Babiker A., Garner P., Artesunate combinations for treatment of malaria: meta-analysis. The Lancet 2004 363 9402 9 17 2-s2.0-0347285290 10.1016/S0140-6736(03)15162-8 (Pubitemid 38076919)
14. Eastman R. T., Fidock D. A., Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nature Reviews Microbiology 2009 7 12 864 874 2-s2.0-70449732094 10.1038/nrmicro2239
15. Arinaitwe E., Sandison T. G., Wanzira H., Kakuru A., Homsy J., Kalamya J., Kamya M. R., Vora N., Greenhouse B., Rosenthal P. J., Tappero J., Dorsey G., Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children. Clinical Infectious Diseases 2009 49 11 1629 1637 2-s2.0-72849113797 10.1086/647946
16. Price R. N., Potential of artemisinin-based combination therapies to block malaria transmission. Journal of Infectious Diseases 2013 207 11 1627 1629 2-s2.0-84877275611 10.1093/infdis/jit079
17. Sinclair D., Zani B., Donegan S., Olliaro P., Garner P., Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane Database of Systematic Reviews 2009 3 10.1002/14651858.CD007483.pub2 CD007483 2-s2.0-68549122629
18. Naing C., Mak J. W., Aung K., Wonga J. Y. R., Efficacy and safety of dihydroartemisinin-piperaquine for treatment of uncomplicated plasmodium falciparum malaria in endemic countries: meta-analysis of randomised controlled studies. Transactions of the Royal Society of Tropical Medicine and Hygiene 2013 107 2 65 73 2-s2.0-84879601438 10.1093/trstmh/trs019
19. Olliaro P., Pinoges L., Checchi F., Vaillant M., Guthmann J.-P., Risk associated with asymptomatic parasitaemia occurring post-antimalarial treatment. Tropical Medicine and International Health 2008 13 1 83 90 2-s2.0-39449104831 10.1111/j.1365-3156.2007.01977.x (Pubitemid 351271393)
20. Shaukat A. M., Gilliams E. A., Kenefic L. J., Laurens M. B., Dzinjalamala F. K., Nyirenda O. M., Thesing P. C., Jacob C. G., Molyneux M. E., Taylor T. E., Plowe C. V., Laufer M. K., Clinical manifestations of new versus recrudescent malaria infections following anti-malarial drug treatment. Malaria Journal 2012 11, article 207 2-s2.0-84862266048 10.1186/1475-2875-11-207
21. Moher D., Liberati A., Tetzlaff J., Altman D. G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine 2009 6 7 10.1371/journal.pmed.1000097 e1000097
22. Higgins J. P. T., Green S., Cochrane Handbook for Systematic Reviews of Interventions 2008 Chichester, UK Wiley-Blackwell
23. Bax L., Yu L.-M., Ikeda N., Moons K. G. M., A systematic comparison of software dedicated to meta-analysis of causal studies. BMC Medical Research Methodology 2007 7, article 40 2-s2.0-35748956807 10.1186/1471-2288-7-40 (Pubitemid 350045994)
24. Simon S. D., Statistical Evidence in Medical Trials: What Do the Data Really Tell Us? 2006 Oxford, UK Oxford University Press
25. Guyatt G. H., Oxman A. D., Vist G. E., Kunz R., Falck-Ytter Y., Alonso-Coello P., Schünemann H. J., GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. British Medical Journal 2008 336 7650 924 926 2-s2.0-43049113533 (Pubitemid 351632017)
26. Balshem H., Helfand M., Schünemann H. J., Oxman A. D., Kunz R., Brozek J., Vist G. E., Falck-Ytter Y., Meerpohl J., Norris S., Guyatt G. H., GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011 64 4 401 406 2-s2.0-79951955198 10.1016/j.jclinepi.2010.07.015
27. Borenstein M., Hedges L. V., Higgins J. P. T., Rothshstein H. R., A basic introduction to fixed-effect and random-effects models for meta-analysis. Research Synthesis Methods 2010 1 2 97 111
28. Higgins J. P. T., Thompson S. G., Deeks J. J., Altman D. G., Measuring inconsistency in meta-analyses. British Medical Journal 2003 327 7414 557 560 2-s2.0-0041876133 (Pubitemid 37088507)
29. Adam I., Salah M. T., Eltahir H. G., Elhassan A. H., Elmardi K. A., Malik E. M., Dihydroartemisinin-piperaquine versus artemether-lumefantrine, in the treatment of uncomplicated Plasmodium falciparum malaria in central Sudan. Annals of Tropical Medicine and Parasitology 2010 104 4 319 326 2-s2.0-77954702591 10.1179/136485910X12743554760144
30. Kamya M. R., Yeka A., Bukirwa H., Lugemwa M., Rwakimari J. B., Staedke S. G., Talisuna A. O., Greenhouse B., Nosten F., Rosenthal P. J., Wabwire-Mangen F., Dorsey G., Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial. PLoS Clinical Trials 2007 2 5, article e20 2-s2.0-34249862105 10.1371/journal.pctr.0020020 (Pubitemid 46860146)
31. Mens P. F., Sawa P., van Amsterdam S. M., Versteeg I., Omar S. A., Schallig H. D. F. H., Kager P. A., A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya. Malaria Journal 2008 7, article 237 2-s2.0-57549092697 10.1186/1475-2875-7-237
32. Bassat Q., Mulenga M., Tinto H., Piola P., Borrmann S., Menéndez C., Nambozi M., Valéa I., Nabasumba C., Sasi P., Bacchieri A., Corsi M., Ubben D., Talisuna A., D'Alessandro U., Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial. PLoS ONE 2009 4 11 2-s2.0-70849087812 10.1371/journal.pone.0007871 e7871
33. Yavo W., Faye B., Kuete T., Djohan V., Oga S. A., Kassi R. R., Diatta M., Ama M. V., Tine R., Ndiaye J.-L., Evi J.-B., Same-Ekobo A., Faye O., Koné M., Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa. Malaria Journal 2011 10, article 198 2-s2.0-79960562239 10.1186/1475-2875-10-198
34. Sawa P., Shekalaghe S. A., Drakeley C. J., Sutherland C. J., Mweresa C. K., Baidjoe A. Y., Manjurano A., Kavishe R. A., Beshir K. B., Yussuf R. U., Omar S. A., Hermsen C. C., Okell L., Schallig H. D. F. H., Sauerwein R. W., Hallett R. L., Bousema T., Malaria transmission after artemether-lumefantrine and dihydroartemisinin- piperaquine: a randomized trial. Journal of Infectious Diseases 2013 207 11 1637 1645 2-s2.0-84877311728 10.1093/infdis/jit077
35. Yeka A., Dorsey G., Kamya M. R., Talisuna A., Lugemwa M., Rwakimari J. B., Staedke S. G., Rosenthal P. J., Wabwire-Mangen F., Bukirwa H., Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. PLoS ONE 2008 3 6 2-s2.0-48649096145 10.1371/journal.pone.0002390 e2390
36. Nambozi M., van Geertruyden J.-P., Hachizovu S., Chaponda M., Mukwamataba D., Mulenga M., Ubben D., D'Alessandro U., Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children. Malaria Journal 2011 10, article 50 2-s2.0-79952051804 10.1186/1475-2875-10-50
37. Verret W. J., Arinaitwe E., Wanzira H., Bigira V., Kakuru A., Kamya M., Tappero J. W., Sandison T., Dorsey G., Effect of nutritional status on response to treatment with artemisinin-based combination therapy in young Ugandan children with malaria. Antimicrobial Agents and Chemotherapy 2011 55 6 2629 2635 2-s2.0-79956294759 10.1128/AAC.01727-10
38. Katrak S., Gasasira A., Arinaitwe E., Kakuru A., Wanzira H., Bigira V., Sandison T. G., Homsy J., Tappero J. W., Kamya M. R., Dorsey G., Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children. Malaria Journal 2009 8 1, article 272 2-s2.0-72849137417 10.1186/1475-2875-8-272